Look out for COVID-19 scams

Breaking News
290

Translate to Spanish or other 102 languages!

Image for illustration purposes only

Mega Doctor News

- Advertisement -

Unfortunately, scammers are using the COVID-19 pandemic to try to steal your Medicare Number, personal information, and money. And they’re using robocalls, social media posts, and emails to do it. 

Remember, if anyone reaches out to get your Medicare Number or personal information in exchange for something, you can bet it’s a scam.

Prevent Medicare Fraud

Be on the lookout, so you can stop scams before they happen. Here are recent Coronavirus scams to watch for:

- Advertisement -
  • Robocalls offering you respiratory masks they’ll never send
  • Social media posts fraudulently seeking donations for non-existent charities, or claiming to give you stimulus funds if you enter your bank account information
  • Fake testing kits, cures, “immunity” pills, and offers for protective equipment

Visit Medicare.gov/fraud for more information and tips on preventing Medicare scams and fraud.

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Cowboy Chicken: We’ve got your mid-week pick-me-up right here (for only $8!)
Next article
Six more people in Hidalgo County test positive for COVID-19

More Articles

Embolism Treatment Developed at University of Michigan receives FDA clearance 

Patients with persistent blood clots require frequent medical interventions just to survive. Yet despite this critical need, there have been few advancements in how these patients are treated. 

FDA Approves Once-Weekly Generic Hormone Therapy Patch for Women

The U.S. Food and Drug Administration approved the first generic of Climara Pro (estradiol and levonorgestrel transdermal system, 0.045 mg per day/0.015 mg), a transdermal hormone therapy patch for women with an intact uterus applied once a week. The approval aligns with FDA’s Public Health Pillar: Increasing Access to Affordable Medicines & Medical Products.

FDA Approves Immunotherapy Regimen Studied by Mayo Clinic for Stage 3 Colon Cancer

The Food and Drug Administration (FDA) has approved the immunotherapy drug atezolizumab in combination with chemotherapy for some patients with stage 3 colon cancer following surgery. The treatment is for patients whose tumors have deficient DNA mismatch repair, or dMMR.

Texas Oncology Expands Cancer Care With New McAllen West Clinic

Texas Oncology celebrated the grand opening of its McAllen West clinic Sept. 29, expanding cancer treatment, diagnostic, and research capabilities in the Rio Grande Valley as the organization continues its presence in the region, spanning more than 40 years.
- Advertisement -